Videos

Lakdawala and Vernon’s session discusses the changing landscape of hormonal contraception and pharmacists’ roles within it.

Nazia Somani Babul, PharmD, BCACP, discussed her presentation about nontraditional pharmacy models, and particularly a model at her facility focused on comprehensive pain management counseling.

Pharmacists at this clinic work with patients to improve medication education, affordability, and access to care.

Michael Singel, PharmD, discusses the role of pharmacists in the operationalization of bispecifics to treat multiple myeloma, including the creation of treatment plans and standard of care order sets.

Michael Singel, PharmD, discusses the logistics of complying with the Risk Evaluation and Mitigation Strategy program for bispecific antibodies at his institution and addresses training and documentation requirements.

Triona Schmelter discusses Opill’s availability, pricing, effectiveness, safety, and impact on addressing barriers to contraceptive access.

Laura Brown, MS, RDN, LDN, discusses the importance of National Nutrition Month, collaborating with pharmacists, promoting sustainable eating habits, and overcoming common nutrition misconceptions

Mila Felder, MD, FACEP, discusses Advocate Aurora Health’s approach to addressing burnout among health care professionals in health care systems.

Women who have longer ovarian function and enter menopause later in life tend to live longer, according to women’s health researcher.

Amina Abubakar, PharmD, AAHIVP, discussed her work throughout Africa and particularly in Kenya.

Raj Gupta, DC, discusses holistic approaches to managing type 2 diabetes without medication by addressing root causes like diet, toxins, and stress.

Menopause can have severe repercussions on female health which impact quality of life and health span, according to an expert of women’s health.

Carol Ann Huff, MD, describes her institution's multidisciplinary approach to monitoring for adverse events when administering bispecific antibodies, including the roles of nurses, pharmacists, and attending physicians.

Michael Singel, PharmD; and Carol Ann Huff, MD, discuss how step-up dosing for bispecific antibodies has been implemented in the outpatient setting with monitoring considerations for cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome to ensure patient safety.

The vice president and chief pharmacy officer at City of Hope explains how she serves as a mentor for women within health care, the importance of networking, and staying educated.

The vice president and chief pharmacy officer of City of Hope discusses obstacles women face in health care and how diversity, equity, and inclusion can be promoted within the space.

“I see clinical pharmacy specialists (CPS) to be more like the frontline folks that would pretty much work very closely with the providers,” according to a CPS at City of Hope.

Tune into this episode of “Public Health Matters” for valuable insights into the intersection of entertainment, health care, and child advocacy, highlighting the importance of creating supportive and interactive environments for pediatric patients.

Panelists provide concluding perspectives on the operationalization of bispecific antibodies for multiple myeloma.

Jon Martin, US commercial lead of biosimilars at Organon, discusses how making their biosimilar Hadlima the preferred product on the Veteran Affairs formulary will help lower treatment costs.

Experts discuss challenges related to the implementation of bispecific antibodies for the treatment of multiple myeloma and emphasize the critical role of interinstitutional collaboration in developing bispecific antibody programs.

There is a growing number of technologies, processes, and treatments being discovered in the quest to extend life.

Experts review comprehensive strategies to enhance patient safety and responsible opioid management across assessment, monitoring, alternatives, and collaboration.

Health care providers discuss how prefilled syringes reduce diversion risks, enhance waste management, and offer cost-effective solutions, ensuring compliance with regulations.

Many psychedelics being studied for clinical use are not "magic mushrooms", rather clinical drugs formulated using good manufacturing practice standards.

In addition to current treatment regimens, 2 experts discuss how available options can vary between adult and pediatric patients.

Experts sheds light on gaps in gender and use of referrals, health literacy, and medication access in the treatment of patients with heart failure.

Investigators continue to conduct regulated and controlled clinical trials to build compelling, high-quality evidence on their therapeutic potential.

Experts discuss their institution’s implementation of step-up dosing for bispecific antibodies and share their best practices.

Pharmacists could raise awareness of heart health and CPR through community outreach programs